Our review describing IntoGen titled “A compendium of mutational cancer driver genes” published in Nature Reviews Cancer

By |2023-11-08T09:54:27+00:00September 2nd, 2020|Categories: BG News|Tags: |

In this review, we focus on the history of cancer driver genes identification from the beginning of cancer research through the advent of cancer genomics and [...]

Comments Off on Our review describing IntoGen titled “A compendium of mutational cancer driver genes” published in Nature Reviews Cancer

OncodriveROLE predicts activating and loss of function cancer driver genes

By |2023-11-08T09:54:28+00:00August 26th, 2014|Categories: BG News|Tags: , , , , , , |

We are pleased to announce that the Oncodrive methods family has a new member: OncodriveROLE, an approach to classify cancer drivers into loss of function and activating [...]

Comments Off on OncodriveROLE predicts activating and loss of function cancer driver genes

New IntOGen Somatic Mutations Analysis version available

By |2023-11-08T09:54:29+00:00March 12th, 2013|Categories: BG News|Tags: , , , , , , , , , , |

We are proud to announce the brand new version of the IntOGen Somatic Mutations Analysis (IntOGen SM) pipeline. We call it version 2.0.0 as it has been completely [...]

Comments Off on New IntOGen Somatic Mutations Analysis version available

Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expression.

By |2023-11-08T09:54:30+00:00February 11th, 2013|Categories: BG News|Tags: , , |

One of the current challenges of oncogenomics is to elucidate which of the aberrations observed in the cancer genome is involved in the disease and which of [...]

Comments Off on Oncodrive-CIS: a method to reveal likely driver genes based on the impact of their copy number changes on expression.
Go to Top